Your browser doesn't support javascript.
loading
Total Daily Production and Periodicity of Melatonin Metabolite in Critically Ill Children.
Foster, Jennifer R; Tijssen, Janice A; Miller, Michael R; Seabrook, Jamie A; Fraser, Douglas D.
Afiliação
  • Foster JR; Department of Critical Care, Dalhousie University, Halifax, NS, Canada.
  • Tijssen JA; Department of Pediatrics, Western University, London, ON, Canada.
  • Miller MR; Lawson Health Research Institute, London, ON, Canada.
  • Seabrook JA; Children's Health Research Institute, London, ON, Canada.
  • Fraser DD; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
Pediatr Crit Care Med ; 21(12): e1061-e1068, 2020 12.
Article em En | MEDLINE | ID: mdl-32701747
ABSTRACT

OBJECTIVES:

To determine whether total daily 6-sulfatoxymelatonin excretion and diurnal variation of melatonin secretion was maintained during the early phase of PICU admission through examination of the melatonin urinary metabolite, 6-sulfatoxymelatonin.

DESIGN:

Exploratory prospective, observational study.

SETTING:

Twelve-bed medical-surgical PICU of a Children's Hospital. PATIENTS Fifty children 3 months to 18 years old enrolled within 24 hours of PICU admission with access for urinary sampling.

INTERVENTIONS:

None. MEASUREMENTS AND MAIN

RESULTS:

Urine samples were collected at 4-hour intervals for 24 hours and stored at -80C. 6-sulfatoxymelatonin was determined in duplicate by direct enzyme-linked immunosorbent assay. Patients were heterogeneous for diagnosis, had a mean age of 8.1 years (SD = 6.1 yr), and median (interquartile range) Pediatric Risk of Mortality III of 10 (4-13). Mean (SD) total daily 6-sulfatoxymelatonin production was 30.0 µg (25.6 µg) for the first 24 hours, which did not differ significantly from the means on days 2 (p = 0.56) or 3 (p = 0.29), and was similar to literature controls. Mean 6-sulfatoxymelatonin production for the population fit a periodic function well, with a reliable amplitude of 326 ng/hr and peak excretion from 0400 to 0800 (F = 4.4, p = 0.01), even when 6-sulfatoxymelatonin was corrected for body weight (F = 3.4, p = 0.03) and when sedation was included in the model (F = 3.95, p = 0.004). There was no significant correlation between lighting and 6-sulfatoxymelatonin excretion at any time period (R values 0.11-0.25, p = 0.10-0.94). Mean 6-sulfatoxymelatonin excretion did not fit the model for a periodic function well for the subpopulations studied (sepsis [n = 18, F = 1.1, p = 0.32], respiratory failure requiring deep sedation [n = 10, F = 0.4, p = 0.66], and neurologic injury [n = 7, F = 0.6, p = 0.55]).

CONCLUSIONS:

Total daily and diurnal variation of 6-sulfatoxymelatonin excretion is heterogeneously maintained early in pediatric critical illness. However, this may not hold true for specific diagnostic categories.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse / Melatonina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sepse / Melatonina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2020 Tipo de documento: Article